Epilepsy News

Nocturnal hypoxemia and sleep apnea raised the risk for late-onset epilepsy even after adjustment for several risk factors and comorbidities, according to results published in Sleep.

The FDA has granted Regenerative Medicine Advanced Therapy designation to a novel regenerative cell therapy to treat drug-resistant mesial temporal lobe epilepsy, according to the manufacturer.

DENVER — Primary generalized tonic-clonic seizures present unique challenges to adolescents diagnosed with the condition, Sunita Misra, MD, PhD, said in this Healio video at the American Academy of Neurology annual meeting.

DENVER — Treatment with cannabidiol led to significant seizure reduction in those with focal-onset epilepsy and demonstrated a favorable safety profile, according to research presented at the American Academy of Neurology annual meeting.

For those with epilepsy who may become pregnant and their potential offspring, medications must optimize seizure control as well as outcomes for the fetus, according to new guidelines presented in Neurology.

DENVER — Treatment with a novel therapeutic led to clinically significant improvement in cognition for young persons with Angelman syndrome, Kemi Olugemo, MD, FAAN, said in this Healio video at the American Academy of Neurology annual meeting.

The FDA has granted orphan drug designation to a microbiome-modifying biologic to treat Angelman syndrome, according to the manufacturer.

Among adolescents with focal epilepsy, nonmotor seizures are more often missed or misdiagnosed compared with motor seizures, according to research presented in Neurology.

Dana-Farber Cancer Institute launched a neuro-inclusive oncology care and empowerment program designed to support adults with intellectual and/or developmental disabilities on their cancer journeys.

DENVER – A machine-learning seizure burden monitoring algorithm was able to predict the level of poor functional outcomes in those with neurological conditions, according to new research.